Journal of Cardiac Failure
Volume 13, Issue 6 , Pages 437-444 , August 2007

Baseline and Serial Neurohormones in Patients With Congestive Heart Failure Treated With and Without Bucindolol: Results of the Neurohumoral Substudy of the Beta-Blocker Evaluation of Survival Study (BEST)

  • Robert P. Frantz, MD

      Affiliations

    • From the Division of Cardiovascular Diseases, Mayo Clinic College of Medicine and Mayo Foundation, Rochester, Minnesota
    • Corresponding Author InformationReprint requests: Robert P. Frantz, MD, Division of Cardiovascular Diseases, Mayo Clinic, 200 1st St SW, Rochester MN 55905.
    • ,
  • Brian D. Lowes, MD

      Affiliations

    • University of Colorado Health Sciences Center, Denver, Colorado
    • ,
  • Paul A. Grayburn, MD

      Affiliations

    • Current affiliation: Baylor University Medical Center, Dallas, Texas.
    • VAMC Dallas, Dallas, Texas
    • ,
  • Michel White, MD

      Affiliations

    • Montreal Heart Institute, Washington, DC
    • ,
  • Heidi Krause-Steinrauf, MS

      Affiliations

    • George Washington University, Washington, DC
    • ,
  • Vaishali Krishnan, BS

      Affiliations

    • VA Cooperative Studies Program, Palo Alto, California
    • ,
  • Lauren Uyeda, MA

      Affiliations

    • VA Cooperative Studies Program, Palo Alto, California
    • ,
  • John C. Burnett, MD

      Affiliations

    • From the Division of Cardiovascular Diseases, Mayo Clinic College of Medicine and Mayo Foundation, Rochester, Minnesota
    • ,
  • for the BEST Neurohumoral Substudy Investigators

Received 29 September 2006 ,Revised 6 March 2007 ,Accepted 16 March 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 BEST was sponsored by the Division of Epidemiology and Clinical Applications of the National Heart, Lung and Blood Institute and the Department of Veterans Affairs Cooperative Studies Program through an interagency agreement. Additional support was provided by Incara Pharmaceuticals Corporation, which also supplied bucindolol and placebo. The authors have no conflicts of interest or relevant financial disclosures to report.

PII: S1071-9164(07)00098-X

doi: 10.1016/j.cardfail.2007.03.007

Journal of Cardiac Failure
Volume 13, Issue 6 , Pages 437-444 , August 2007

Article Tools

* Image Usage & Resolution